Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug Toxicity”

447 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 447 results

Not applicableStudy completedNCT06447259
What this trial is testing

Drug Burden Index is Associated With Malnutrition in Community-dwelling Dementia Patients

Who this might be right for
Malnutrition SevereDementiaDrug Use+1 more
Sultan Keskin Demircan 415
Post-approval studies (Phase 4)Looking for participantsNCT05471479
What this trial is testing

Activated CHARcoal in Poisoned Patient - Pilot Trial

Who this might be right for
Charcoal, Decontamination, Poisoning
Laval University 100
Not applicableLooking for participantsNCT05981573
What this trial is testing

Assessment of Methadone Dose Taken

Who this might be right for
Methadone ToxicityMethadone OverdosePain, Chronic+2 more
Cari Health Inc. 30
Testing effectiveness (Phase 2)Ended earlyNCT01783522
What this trial is testing

Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib

Who this might be right for
Chemotherapeutic Agent ToxicityMultiple MyelomaPeripheral Neuropathy
Beth Faiman 9
Testing effectiveness (Phase 2)Study completedNCT06782022
What this trial is testing

DPD Guided 5-FU Precision Treatment in Gastro-intestinal Cancer Patients

Who this might be right for
Gastrointestinal Cancers
Jan Gerard Maring 80
Not applicableUnknownNCT01208545
What this trial is testing

Serial Electrophysiologic Monitoring During Administration of Nerve-Toxic Chemotherapeutic Drugs

Who this might be right for
ChemotherapyNerve DegenerationNerve Conduction
NeuroMetrix, Inc. 120
Not applicableStudy completedNCT02805686
What this trial is testing

" En Face " OCT's Contribution in the Detection of Macular Retinal Toxicity Signs Linked to the Chronic Treatment of Synthetic Antimalarials

Who this might be right for
Maculopathy
Fondation Ophtalmologique Adolphe de Rothschild 45
Not applicableUnknownNCT03797339
What this trial is testing

Multi-omics Study of Clinical Endpoints in CHD

Who this might be right for
Coronary Heart Disease
Guangdong Provincial People's Hospital 4,000
Not applicableUnknownNCT04696081
What this trial is testing

Atrial Fibrillation in Active Cancer Patients

Who this might be right for
CancerDrug ToxicityAtrial Fibrillation+1 more
University Hospital, Caen 1,000
Early research (Phase 1)Study completedNCT00003144
What this trial is testing

Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganUnspecified Adult Solid Tumor, Protocol Specific
NYU Langone Health 44
Large-scale testing (Phase 3)UnknownNCT05595109
What this trial is testing

Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients

Who this might be right for
Breast CancerPeripheral NeuropathyCardiac Toxicities+2 more
Tanta University 56
Not applicableUnknownNCT03919539
What this trial is testing

Epigenetic Biomarker for Advanced Osteosarcoma Using Famitinib and Camrelizumab

Who this might be right for
Drug Resistance to Famitinib and CamrelizumabBiomarkers for Efficacy and Toxicity
Peking University People's Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00003225
What this trial is testing

Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Jonsson Comprehensive Cancer Center 23
Not applicableStudy completedNCT03828942
What this trial is testing

Monitoring the HeMAtological TOXicity of Drugs (HeMATOX)

Who this might be right for
Hematological AbnormalityHematotoxicity
Groupe Hospitalier Pitie-Salpetriere 1,000
Not applicableNot Yet RecruitingNCT05377320
What this trial is testing

PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study

Who this might be right for
Heart FailureCoronary Artery DiseasePeripheral Artery Disease+5 more
Medical College of Wisconsin 60
Not applicableUnknownNCT04654195
What this trial is testing

Study of ABCB1,SLC22A16 Drug Transporter Genes and Doxorubicin and Cyclophosphamide Toxicity in Brest Cancer Patient

Who this might be right for
Breast Cancer Patients
Damanhour University 100
Not applicableStudy completedNCT03113136
What this trial is testing

Examination of Low Wattage and High Wattage E-Cigarettes

Who this might be right for
Smoking, CigaretteSmoking, TobaccoNicotine Dependence+1 more
Ohio State University Comprehensive Cancer Center 372
Testing effectiveness (Phase 2)Looking for participantsNCT05559164
What this trial is testing

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

Who this might be right for
Cardiac ToxicityEarly-stage Breast Cancer
Rutgers, The State University of New Jersey 60
Not applicableStudy completedNCT06778122
What this trial is testing

In-Bedroom Renewed Air as Anti-inflammatory Adjuvant Therapy in Cancer Survivors

Who this might be right for
Cancer SurvivorsCardiotoxicityCardiovascular Toxicity Induced by Antitumoral Drugs
University College, London 10
Early research (Phase 1)Study completedNCT00814086
What this trial is testing

Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

Who this might be right for
Chemotherapeutic Agent ToxicityEndometrial AdenocarcinomaFallopian Tube Carcinoma+12 more
Gynecologic Oncology Group 23
Next Page